HTL Biotechnology
VC Fund
Javené, France
HTL Biotechnology is a VC fund in Javené focused on Health Care and Biotechnology. HTL is a manufacturer and research & development of Hyaluronan and other biological polymers by bacterial fermentation.HTL SAS was created in 1992 and is specialized in the manufacture, purification and research and development of Hyaluronan (HA). Today it has diversified and produces other biological polymers (see new products) for thepharmaceutical and medical fields.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries HTL Biotechnology invests in
Stages HTL Biotechnology invests in
Countries HTL Biotechnology invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cyril Picault
|
|||
Glenn Prestwich
|
|||
Susanne Liepmann
|
|||
Yvon Bastard
|
|||
Investment Focus
Industry
- Health Care 2 (100%)
- Biotechnology 2 (100%)
- Medical Device 1 (50%)
- Pharmaceutical 1 (50%)
Country
- France 1 (50%)
- United States 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Cyril Picault
Chief Operating Officer
|
Chief Operating Officer | Total investments: 0 | Find email | |
|
Glenn Prestwich
Science & Innovation Advisor
|
Science & Innovation Advisor | Total investments: 0 | Find email | |
|
Susanne Liepmann
Group CFO
|
Group CFO | Total investments: 0 | Find email | |
|
Yvon Bastard
Chief Executive Officer & Président-Directeur Général
|
Chief Executive Officer & Président-Directeur Général | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Gelmedix
|
Gelmedix is a developer of a biomaterial platform to improve drug delivery for complicated ophthalmic treatment. The company's platform offers a single non-invasive gel patch that can be used as a drug-eluting sealant with tissue adhesion, tunable drug elution, and biocompatibility properties, thereby enabling healthcare providers to reducethe usage of drops which cause inconvenience to patients. | $13M / Seed / Feb 17, 2026 | |
BIOPHTA
|
BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management. | $7.1M / Seed / Jun 03, 2024 |
Co-Investors
Safar Partners
2 deals together
Beacon Angels
1 deal together
Boston Harbor Angels
1 deal together
Elaia
1 deal together
GO CAPITAL
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does HTL Biotechnology invest in?
HTL Biotechnology invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact HTL Biotechnology?
Public channels for HTL Biotechnology include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HTL Biotechnology?
The team at HTL Biotechnology includes Cyril Picault (Chief Operating Officer), Glenn Prestwich (Science & Innovation Advisor) and Susanne Liepmann (Group CFO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
